May 6, 2004 by Brian GormanDisney's TrapDisney's decision to block the release of Michael Moore's new film plunges it into a political boondoggle.
May 5, 2004 by Brian GormanAlbany Molecular Gets Out-OutsourcedAlbany Molecular is suffering from the loss of business to low-cost competitors overseas.
May 4, 2004 by Brian GormanIs Water Worth Its Salt?The growth in interest for desalination technologies may offer investment possibilities.
May 3, 2004 by Brian GormanBud Looks EastBudweiser's purchase of a stake in China's Harbin Brewery is wise.
Apr 30, 2004 by Brian GormanCampbell Goes ArtsyThe Warhol-style cans are a clever way to spark interest in the condensed soups. But there's lots more work to do.
Apr 29, 2004 by Brian GormanMerck, Bristol-Myers Team UpTheir agreement to commercialize a diabetes drug reflects intense sales competition in the industry.
Apr 28, 2004 by Brian GormanA New Taste of Yum!KFC is rolling out a new line of "oven roasted" chicken. But is fried food the problem with KFC?
Apr 27, 2004 by Brian GormanBoeing's Dream Comes TrueThe company's fuel-efficient 7E7 Dreamliner could rule the skies.
Apr 26, 2004 by Brian GormanLibya, Ho!The U.S.'s relaxation of sanctions on Libya may be a boon to some oil concerns.
Apr 22, 2004 by Brian GormanBausch & Lomb DeliversThe company's sales aren't sizzling, but its profitability is improving.
Apr 21, 2004 by Brian GormanCheesecake's Rich ResultsThe key to Cheesecake Factory's success is good food and lots of it.
Apr 20, 2004 by Brian GormanPPD's New PossibilitiesThe royalty stream from dapoxetine could significantly boost earnings.
Apr 19, 2004 by Brian GormanLockheed Martin's Norway ProblemIt's Norway or the highway for Lockheed Martin's Joint Strike Fighter program.
Apr 16, 2004 by Brian GormanIs IBM Gearing Up?IBM's strong hardware sales may be a positive indicator of future consulting work.
Apr 15, 2004 by Brian GormanDaimlerChrysler's Growth Engine?DaimlerChrysler may be on to something with its diesel push.
Apr 12, 2004 by Brian GormanScotts' New TurfScotts has created a pesticide-resistant grass, but concern over its environmental impact may kill it.
Apr 12, 2004 by Brian GormanAbbott Not RewardedThe company's Q1 earnings news was positive, but investors didn't react enthusiastically.
Apr 8, 2004 by Brian GormanGenentech's Healthy ShowingThe company's first-quarter results were impressive, driven by pricey cancer drugs.
